Bellevue Life Sciences Acquisition Corp. (BLAC)
NASDAQ: BLAC · IEX Real-Time Price · USD
10.66
-0.17 (-1.57%)
Mar 26, 2024, 4:00 PM EDT - Market closed

BLAC Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20222021
Cash & Equivalents
0.120
Cash & Cash Equivalents
0.120
Cash Growth
2517.22%-
Total Current Assets
0.120
Other Long-Term Assets
1.10.7
Total Long-Term Assets
1.10.7
Total Assets
1.230.71
Accounts Payable
0.050.01
Current Debt
1.20.4
Other Current Liabilities
0.010.29
Total Current Liabilities
1.260.71
Total Liabilities
1.260.71
Total Debt
1.20.4
Debt Growth
200.00%-
Common Stock
0.030.03
Retained Earnings
-0.06-0.03
Shareholders' Equity
-0.04-0
Net Cash / Debt
-1.08-0.4
Net Cash Per Share
-0.72-0.26
Working Capital
-1.14-0.7
Book Value Per Share
-0.03-0.00
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).